mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.001 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.001 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.002 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |